Soil is considered as a promising environment for discovering and isolating bacterial strains that are able to produce novel natural products. Therefore, a Gram positive Bacillus sp. 7B1 was isolated from a soil sample collected from south AlKarak, Jordan. The bacterial isolate was cultivated, identified and its culture medium was extracted. The crude extract was purified using silica gel column chromatography. The antibacterial activity of the crude extract and the purified fractions was evaluated by agar diffusion test as well as by measuring the minimum inhibitory concentration in microbroth dilution assay. The produced crude extract was active only against the tested Gram positive bacteria, namely Bacillus subtilis, Micrococcus luteus and Staphylococcus aureus. Bioactivity-guided fractionations of the resulted crude extract led to the purification of compound (C 2 ). In the present work, Micrococcus luteus was the most susceptible bacterial test strain to compound (C 2 ) with a minimum inhibitory concentration of 25 µg/ml. Our findings highlighted the importance of soil bacterial isolates for production of compounds with interesting bioactivities that may contribute to the drug research field.
Introduction
Microorganisms are able to synthesize secondary metabolites of various structures and, hence, bioactivities. Their production is regulated by nutrients, growth rate, enzyme inactivation and induction (Demain, 1998) . They are produced to help the organism in competing successfully with other organisms in their natural habitat and to adapt with the changed environmental conditions (Teasdale et al., 2008) . These metabolites have played a key role in the discovery and development of many antibiotics (Motta et al., 2004) . Consequently, a large number of drugs approved for marketing nowadays are of microbial origin (Harvey, 2008; Butler et al., 2014) .
Despite the large number and diversity of these metabolites and due to the emergence of new infectious diseases and resistant pathogens that represent a serious problem for human life (Cragg et al., 1997; El-Banna et al., 2007; Disriac et al., 2013) , the need for new therapeutic agents from nature is still urgent. As less than 1% of soil bacterial species are currently known (Torsvik and Ovreas, 2002) , soil represents a promising habitat for discovering and isolating new natural products (MacNeil, 2001) .
Various reports confirmed the ability of Bacillus species to produce antimicrobial agents and compounds with potential biotechnological and pharmaceutical applications (Awais et al., 2007; Hassan, 2014) . In addition, numerous studies were conducted on the bioactivity of crude extracts produced by bacterial strains isolated from different habitats in Jordan. Soil Streptomyces species were able to inhibit the growth of multi-drug resistant Pseudomonas aeruginosa (Saadoun et al., 2008) ; actinomycin C2 and actinomycin C3 were isolated from red soil Actinomyces strain and were reported to inhibit the growth of both Micrococcus luteus and Staphylococcus aureus (Falkinham et al., 2009); ElBanna et al. (2007) showed that the substances produced by different Bacillus species isolated from various Jordanian sources have antibacterial activity against methicillin-resistant S. aureus.
In an ongoing work on natural products from microorganisms and due to our interest in isolating soil bacterial strains with the ability to produce biologically active metabolites, herein, we report the isolation, identification, cultivation and extraction of bioactive crude extract from a soil Bacillus sp. 7B1. Moreover, partial purification of the resulted crude extract using chromatographic methods is described.
Materials and Methods

Isolation and Identification of Bioactive Crude Extract Producing Strain
Bacillus sp. 7B1 was isolated from a soil sample collected from Al-Mazar (south of Al-Karak, Jordan). One gram of the sample was suspended in 10 ml sterile normal saline (0.85% NaCl) and serially diluted up to 10 and yeasts. The agar plates were incubated at 27 °C and the isolate was streaked several times till a pure culture is obtained. 2 ml of Bacillus sp. 7B1 culture medium was stored in 80% glycerol (1:1) at -20 °C for further use.
Bacillus sp. 7B1 was characterized morphologically (colony form and appearance, cell shape and size, etc.) and biochemically (Gram stain, oxidase, catalase, nitrate reduction, etc.) for 48-72 hours grown colonies on Nutrient Agar plates. The biochemical characteristics were determined using procedures described by Collins et al. (2004) and York et al. (2007) . The production of acid from different carbohydrates was done as described by Helmke and Weyland (1984) . Moreover, the identification of the isolate was confirmed using the commercial MICROGEN® BACILLUS-ID kit (Microgen bioproducts, UK) provided with Microgen Identification System Software (MID-60).
Bacterial Cultivation, Extraction and Purification of Produced Bioactive Crude Extract With Partial Characterization of The Active Compound
Bacillus sp. 7B1 was inoculated in 20 L of LuriaBertani (LB) broth (0.5% tryptone, 0.5% yeast extract, 1% NaCl) (8 X 5 L Erlenmeyer flasks containing 2.5 L broth) with continuous shaking (130 rpm) at 27 °C. During the cultivation process, 50 ml daily samples were collected and used to measure the changes in the bacterial growth parameters and the increases in bioactivity. The growth was followed by measuring the increase in turbidity reading (OD 600nm ) (UV. Spectrometer, Lambda 16, Perkin-Elmer, LANGEN) and changes in pH values while the bioactivity was measured by the agar diffusion test against B. subtilis. The cultivation was ended directly after the OD 600nm value decreased or the bioactivity reached its maximum. The cells were harvested by centrifugation (8000 rpm, 15 min, Sorvall ® RC-5B Refrigerated super speed, Dupont company/USA). The pH of the supernatant was adjusted to 8 and extracted with an equal volume of ethyl acetate. The organic phase was dried over sodium sulfate (anhydrous) and concentrated in vacuo at 45 °C using vacuum evaporator (Büchi Rotavapor R-215, Switzerland). The resulting crude extract was dissolved in methanol to 50 mg/ml and stored at 4 °C.
The resulting crude extract was applied onto a column of silica gel (Merck 60, 0.063-0.2 µm, Ø 3 cm x 14 cm). An elution was performed with organic solvents of increasing polarity starting from 100% cyclohexane through cyclohexane-ethyl acetate mixture, ethyl acetatemethanol mixture till 100% methanol as mobile phase and under atmospheric pressure. Each eluted fraction was collected and monitored by Thin Layer Chromatography (TLC) and used to measure its bioactivity by agar diffusion test. The fractions that exhibited bioactivity were further purified using size exclusion chromatography (Sephadex LH-20, Ø 3 cm x 33 cm) with 0.1% formic acid : methanol as eluent under atmospheric pressure. 10 ml fractions were collected and monitored by TLC. The fractions with bands of similar migration pattern on TLC were combined together and concentrated in vacuo using vacuum evaporator at 45 °C.
The resulting combined fractions were further purified by preparative TLC (PTLC) (20 cm x 20 cm glass plates coated with Merck 60 silica gel) using the Toluene : acetone : formic acid as mobile phase (30 : 70: 1). Each resulting band was scratched from the plate and its constituents were dissolved in acetone. The dissolved constituents were used to follow the bioactivity by agar diffusion test and the purity was tested by re-spotting them on TLC plates. The spotted compounds were detected using UV light at 254 nm and 366 nm. Moreover, developed spots were visualized with ninhydrin (0.1% spray-reagent of 2,2-dihydroxyin-1,3-dandion) with heating at 120 °C for detection of amino acids; bromocresol green (0.1 g bromocresol green in 500 ml ethanol and 5 ml 0.1 M NaOH) for detection of organic acid; and bromothymol blue (0.1% bromothymol blue in 10% aqueous ethanol) for detection of lipid and phospholipids (Touchstone, 1992) .
In Vitro Antibacterial Activity Measurement
Antibacterial activities of the bacterial crude extract, partially purified fractions and the resulting pure compound, were determined by agar diffusion test; the minimum inhibitory concentration (MIC) was also measured by microbroth dilution assay using the standard methods mentioned in Clinical and Laboratory Standards Institute (CLSI, 2012) and as described by Al-Zereini (2014 500 µg of crude extract or 200 µg of the partially purified fractions was applied on a 6-mm blank filter disk and used in the agar diffusion test, while concentrations starting from 100 µg/ml of purified compound or positive control (Penicillin G) were used in microbroth dilution assay to measure the MIC. The biostatic or biocidal effect of the tested compounds was determined by re-streaking 10 µl from the culture in the first well where there is no obvious growth on a new Nutrient Agar plate. All assays were performed in triplicate and the average values are presented.
Results and Discussion
Throughout the present study, one bacterial isolate (Bacillus sp. 7B1) exhibited a promising bioactivity against the tested bacterial strains. Bacillus sp. 7B1 formed circular creamy yellow colonies on Nutrient Agar Medium. It is a Gram positive, 2-2.5 µm long and 1 µm wide bacilli (Figure 1 ), oxidase negative, catalase positive, hydrolyze starch and is able to reduce nitrate to nitrite. The biochemical characteristics are summarized in Table 1 . It was identified with a 99% similarity to species belonging to the genus Bacillus by the Microgen Identification System Software (MID-60) supplied with the MICROGEN® BACILLUS-ID kit The cultivation of Bacillus sp. 7B1 was carried out for 196 hours, during which the pH value increased from 7.1 up to 8.5 at the end of cultivation period; the cells entered the stationary phase after 120-144 hours and the cultivation ended after the ODR 600nm R value started to decrease and the bioactivity of the crude extracts from daily samples reached their maximum. In contrary to typical idiolites (secondary metabolites that are produced during idiophase or stationary phase), the antibacterial activity of 500 µg/disc crude extract against B. subtilis could be detected early in the logarithmic growth phase (exponential phase), after 48 hours. The maximum activity was obtained at the beginning of the stationary growth phase, with no significant decrease during prolonged incubation (Figure 2) . The crude extract, at 500 µg/disc, of strain 7B1 exhibited a promising anti-bacterial activity against the Gram positive test strains. It caused inhibition zones of 16, 18 and 26 mm against S. aureus, B. subtilis and M. luteus, respectively. Gram negative bacteria were resistant to the tested crude extract. This resistance may be attributed to the low permeability of the Gram negative bacteria outer membrane and the lipopolysaccharide barrier for the hydrophobic compounds (Delcoue, 2009; Wiener and Horanyi, 2011) .
Several studies reported that Bacillus strains were able to produce a large number of antimicrobial peptides with different chemical structures, such as bacteriocins, iturin A and surfactin (Belhara et al., 2011) . The production of these metabolites was reported to be a growth phasedependent and produced, as typical secondary metabolites, during the stationary growth phase (Benitez et al., 2012) . However, the early noticed production of the bioactive crude extract from Bacillus sp. 7B1 coincided with reported production kinetics observed for other antimicrobial peptides, namely subtilin, subtilosin and bacteriocin-like substances by different Bacillus species (Barboza-Corona et al., 2007; Stein, 2005) . Nevertheless, the proteinaceuos nature of spotted compounds from Bacillus sp. 7B1 was not confirmed after spraying the TLC plates with ninhydrin reagent.
The extraction of culture fluid (19 L) with ethyl acetate yielded 859 mg of crude extract. Bioactivityguided fractionations of the crude extract using silica gel column chromatography resulted in elution of eight fractions, three of which are polar antibacterial fractions (E-G) (Figure 3 ). Further purification of the combined bioactive fractions on sephadex LH-20 yielded eight subfractions. Only sub-fraction SR 3 R (100 mg) conferred antibacterial activity and caused an inhibition zone of 18 mm to B. subtilis at 200 µg/disc. Generally, the percentage of the bioactive compound in the resulting fractions after each step of purification is increased and, thus, it exhibits an activity at a concentration less than that at the beginning of screening. Therefore, in the agar diffusion test, we started our screening with a higher concentration of crude extract (500 µg/disc) and after each step of purification, the fractions were examined at a concentration of 200 µg/disc.
The separation of sub-fraction S 3 constituents by preparative TLC resulted in the production of six bands (Figure 4) , of which band number (2) (rate of flow, R f : 0.25) was the only band that revealed an antibacterial activity in the agar diffusion test. Scratching of band number (2) from TLC plate, dissolving it in acetone followed by drying in vacuo using vacuum evaporator and re-spotting on a new TLC plate to examine its purity resulted in 10 mg of pure white colored compound (C 2 ). 50 µg/disc of compound (C 2 ) caused inhibition zones of 13, 15 and 17 mm against S. aureus, B. subtilis and M. luteus respectively. In microbroth dilution assay, the MIC value of compound (C 2 ) was 25-100 µg/ml (Table 2) . Compound (C 2 ) had a bacteriostatic effect as it inhibited growth but did not kill the tested microorganisms. This may enable the human immune system to take its role and overwhelm the bacterial infections , especially those caused by Gram positive bacteria. In contrary to bacteriostatic antibiotics that slow or stop the bacterial growth, usually by inhibiting the protein synthesis without inducing the production of toxic radicals, bactericidal antibiotics promote the generation of hydroxyl radicals and, thus, leading to bacterial cell death (Bernatová et al., 2013) . Consequently, bactericidal agents induce ROS overproduction in mammalian cells causing an oxidative damage to DNA, proteins, and membrane lipids and mitochondrial dysfunction (Kalghatgi et al., 2013) . Furthermore, bactericidal agents may cause a sudden increase in the bacterial products and toxins in the human body which may potentially cause a harmful inflammation due to the cytokine production (Finberg et al., 2004) .
Herein, the bioactivity reported for the crude extract and the purified compound (CR 2 R) from Bacillus sp. 7B1 against the methicillin-resistant S. aureus is more than that obtained from similar strains isolated from Jordan. El-Banna et al. (2007) reported that the air flora Bacillus megaterium NB-3 and Bacillus subtilis NB-6 were inactive against some methicillin-resistant Staphylococcus aureus isolates and weakly active to other S. aureus isolates from meat samples collected from retail shops and slaughter houses located in Amman area, Jordan. Unfortunately, due to the low amounts of compound (CR 2 R) obtained from Bacillus sp. 7B1, it was not possible to perform additional physico-chemical characterizations nor structural elucidation. Therefore, a large scale of 100 L cultivation process is intended to be done in the future in order to gain adequate amount of CR 2 R compound and elucidate its chemical structure.
Finally, several antibacterial agents were isolated and identified from several Bacillus species, among which were the B. subtilis group of bacteria including B. amyloliquefaciens (Wulff et al., 2002; Al-Tarawneh, 2011; Cao et al., 2011) . Moreover, they are known as a source of antifungal compounds (Athukorala et al., 2009) and the most promising candidates for microbial biocontrol agents (Arguelles-Arias et al., 2009) . Therefore, Bacillus species may be considered a promising source for isolation secondary metabolites with potential application in pharmaceutical and agricultural industry.
Conclusion
The present study pointed out the importance of soil bacterial isolates as a source of biologically active and potentially novel secondary metabolites. These metabolites are more effective against Gram positive bacteria than Gram negative strains. Moreover, members of the genus Bacillus are still a proliferative group of bacteria with species that are able to produce compounds that may contribute to pharmaceutical industry. 
